Why ODE models for COVID-19 fail: Heterogeneity shapes epidemic dynamics ======================================================================== * Gerrit Großmann * Michael Backenköhler * Verena Wolf ## Abstract In the recent COVID-19 pandemic, mathematical modeling constitutes an important tool to evaluate the prospective effectiveness of non-pharmaceutical interventions (NPIs) and to guide policy-making. Most research is, however, centered around characterizing the epidemic based on point estimates like the average infectiousness or the average number of contacts. In this work, we use stochastic simulations to investigate the consequences of a population’s heterogeneity regarding connectivity and individual viral load levels. Therefore, we translate a COVID-19 ODE model to a stochastic multi-agent system. We use contact networks to model complex interaction structures and a probabilistic infection rate to model individual viral load variation. We observe a large dependency of the dispersion and dynamical evolution on the population’s heterogeneity that is not adequately captured by point estimates, for instance, used in ODE models. In particular, models that assume the same clinical and transmission parameters may lead to different conclusions, depending on different types of heterogeneity in the population. For instance, the existence of hubs in the contact network leads to an initial increase of dispersion and the effective reproduction number, but to a lower herd immunity threshold (HIT) compared to homogeneous populations or a population where the heterogeneity stems solely from individual infectivity variations. **Author summary** Computational modeling can support decision-making in the face of pandemics like COVID-19. Models help to understand transmission data and predict important epidemiological properties (e.g., *When will herd immunity be reached?*). They can also examine the effectiveness of certain measures, and—to a limited extent—extrapolate the dynamics under specific assumptions. In all these cases, the heterogeneity of the population plays an important role. For instance, it is known that connectivity differences in (and among) age groups influence the dynamics of epidemic propagation. Here we focus on two types of differences among individuals: their social interactions and on how infectious they are. We show that only considering population averages (e.g., *What is the average number of contacts of an individual?*) may lead to misleading conclusions, because the individual differences (such as those related to the epidemic *(over-)dispersion*) play an important role in shaping the epidemic dynamics. Many commonly used model classes, such as SEIR-type ODE compartmental models, ignore differences within a population to a large extent. This omission bears the potential of misleading conclusions. ## Introduction At the beginning of 2020, the world was struck by the coronavirus (SARS-CoV-2) pandemic. Faced with the approaching overload of healthcare systems, the international community turned to non-pharmaceutical interventions (NPIs) in an attempt to contain the spread of the pathogen [1]. Computational epidemiological modeling became an important asset to predict the propagation and to evaluate the prospective effectiveness of various measures such as school closings and travel restrictions [2, 3]. For an overview of COVID-19 models and their successes and failures, we refer the reader to [4, 5]. In this work, we highlight the importance of population heterogeneity for computational epidemiology and explain why many models used in the current COVID-19 pandemic do not adequately capture it. In particular, we analyze how individual variations in contact numbers and infectiousness influence the evolution of a pandemic. We use the term *infectiousness* as a property of the host to denote the probability of passing a pathogen, given an established contact to a susceptible individual. We qualitatively study the dynamical evolution based on different properties like the height of the infection peak and the fluctuations of the *effective reproduction number R**t* (average number of secondary infections at time point *t*). Furthermore, we study how this heterogeneity influences the *dispersion* during an epidemic’s evolution. COVID-19 is associated with an exceptional high dispersion and understanding how it emerges is a crucial asset in controlling the pandemic [6]. A noticeable example of heterogeneity in a population’s interaction structure are individuals with extraordinary many contacts, so-called *hubs*. Similarly, super-spreader events refer to temporary gatherings where one infected individual (potentially) infects many others. Early on in the pandemic, it was pointed out that hubs are not accurately captured by many models [7]. The evidence for the importance of hubs and super-spreader events became increasingly conclusive over time [8–11]. The concept of *(over-)dispersion* is closely related [12–14] and is consistently reported for the COVID-19 pandemic [15–19]. In short, this concept reflects that a small number of infected individuals infect many others while most infected individuals infect no one or only very few. Overdispersion can be caused by hubs (many contacts, average transmission probability) but also by individuals with high infectiousness (average contact number, high transmission probability). Different individual levels of infectiousness are a source of further heterogeneity in the population. Viral load levels (and other properties that determine a host’s infectiousness) differ between individuals and within individuals over time [20–23]. While many models include the temporal aspect, the effects of individual variations are not well explored. Moreover, some virus variants are associated with higher infectiousness [24]. In order to study the effects of heterogeneity, we translate an ODE model for the spread of COVID-19 to a stochastic network-based model. More specifically, this work uses contact networks (i.e., graphs) to model individual variations in the number of social contacts. To model the individual viral load variations, we use a randomly drawn infectiousness parameter for each individual. Epidemic spreading on networks is well understood and contact networks are a universal and well-established paradigm for the analysis of complex interaction structures. This paradigm allows us to study population heterogeneity while keeping population averages fixed. In particular, we only compare networks with the same connectivity (i.e., number of edges). We also fix the mean infectiousness (i.e., we only modulate how much an individual may deviate). On this premise, we investigate the effects of population heterogeneity on the emergence of dispersion and the dynamical evolution of the epidemic. We find, for instance, that power-law networks admit a natural early growth of *R**t* and a very high dispersion. Individual differences in infectiousness increase the dispersion even more while they generally weaken the epidemic. Our contributions are as follows: 1. We give an overview of popular COVID-19 models used in the literature and discuss their (implicit) assumptions about a population’s heterogeneity. 2. We show that imposing common interaction structures drastically changes an epidemic’s evolution. 3. We analyze the additional effects of individual viral load variations. 4. We propose a novel method to quantify time-dependent dispersion based on an empirical analysis of simulation runs. Contribution (2) is based on preliminary results that were published during the first COVID-19 wave in the spring of 2020 [25]. ### Organization Our manuscript is structured as follows: We present relevant literature in Section *Related work*. In Section *Method*, we show how to translate ODE models to network-based models and discuss their relationship. Section *Experiments* provides numeral experiments based on synthetically generated random contact networks. *Conclusions* completes the manuscript. ## Related work Mathematical modeling of epidemics is a wide research area to control, predict, and understand epidemics or similar types of propagation processes (like opinions, or computer viruses). Here, we mostly focus on the network-based spreading paradigm [26] and its relation to other model types. In particular, we study which types of population heterogeneity can be expressed and how models are used in the current COVID-19 pandemic. Note that currently all models that study COVID-19 quantitatively suffer from the poor quality of data and uncertainty about parameters [27, 28]. We focus on the three model types, we consider most relevant for epidemiological modeling in general. For a comparative analysis of models specific to COVID-19, we refer the reader to [4, 29]. ### ODE models The most wide-spread epidemiological model type is based on a system of ordinary differential equations (ODEs) in which coupled fractions of individuals in disease compartments change deterministically and continuously over time [30]. Compartments refer to different disease stages (e.g., susceptible (S), infected (I), recovered (R), exposed (E), dead (D)). Most commonly used is the three-compartment SIR-model (cf. Fig. 1). Note that ODE models use a single parameter (*λ*) to model the chance to meet someone (interaction structure) and the probability to transmit the infection. ![Fig 1.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2021/03/26/2021.03.25.21254292/F1.medium.gif) [Fig 1.](http://medrxiv.org/content/early/2021/03/26/2021.03.25.21254292/F1) Fig 1. Schematic overview of model types. ### Population heterogeneity Expressing population heterogeneity is only possible to a very limited degree. The typical way is to introduce additional compartments that encode a membership to a certain group (e.g., *susceptible* and “*younger than 20* “). These extended models are often referred to as *meta-population* [31] models. Apart from that, a homogeneous interaction structure is assumed. Effects like super-spreaders (or overdispersion) are practically not expressible. The same holds for local die-outs. Moreover, the deterministic nature makes it difficult to conceptualize risk and uncertainty. ODE models arise as the mean-field limit of a well-mixed Markov population model (corresponding to a complete graph in the network-based paradigm) [32]. ### COVID-19 Literature abounds with ODE-based COVID-19 models, some methods and applications a summarized in [33]. For instance, Dehning et al. [34] use a model, where the infection rate may change over time to predict a suitable time point to loosen NPIs in Germany. José Lourenço et al. infer epidemiological parameters [35]. Khailaie et al. analyze how changes in the reproduction number affect the epidemic dynamics [36]. Stutt et al. evaluate the effectiveness of NPIs [37]. The spread of COVID-19 was studied for many more countries and settings [38–42]. Other studies use a meta-population approach and group individuals based age [43–46] or region [47–49]. Moreover, [50] and [51] modify ODE models to account for individual variation in susceptibility. Roda et al. use an ODE model to illustrate the general difficulty of predicting the spread of COVID-19 data [52]. Limitations in the applicability of ODE models regarding data from Italy is reported in [53]. Similar results are found by Castro et al. using COVID-19 data from Spain [54]. General concerns are articulated in [55]. ### Branching processes Stochastic branching processes operate in discrete or continuous-time and are useful when studying the underlying stochastic nature of an epidemic. They are based on a tree that grows over time and represents the infected individuals. The children (offspring) of each node represent an individual’s secondary infections and the number of children is drawn from an *offspring distribution* with mean *R* that is provided by the modeler [14, 56–58]. ### Population heterogeneity The offspring distribution makes it straight-forward to encode individual variations in infectiousness or connectivity. The paradigm allows to study random extinction probabilities of the epidemic and the effects of super-spreaders/overdispersion [12]. However, branching processes do not admit a (model intrinsic) saturation due to growing immunity in the population. Moreover, the high level of abstraction makes it difficult to study the effects of NPIs and the characteristics of the spatial diffusion of the pathogen. ### COVID-19 Zhang et al. use a branching process to measure the dispersion of COVID-19 inside China [59] and Endo et al. estimate the dispersion based on local clusters outside China [16]. Moreover, [60] use a branching process to infer epidemiological values and [22] study the influence of temporal viral load variation. Alternative branching process models to study dynamical properties specific to COVID-19 were proposed in [61–63]. ### Network-based models Network-based epidemic models use graphs to express the interactions (edges) among individuals (nodes). They are stochastic in nature and can be formulated in discrete or continuous time. Each node occupies a compartment (node state) at each point in time and infected nodes can (randomly) infect their susceptible neighbors [26, 64, 65]. Generalizations to multi-layer and weighted networks have been suggested [66]. ### Population heterogeneity The network-based paradigm decouples the connectivity of the population from the infectiousness of the virus. Moreover, each individual is represented by an autonomous agent which adds flexibility and makes it straightforward to include individual variations of the population. The key advantage of networks is that they represent a universal way of encoding different types of complex interaction structures like hubs, communities, households, small-worldness, different mixing within in population-groups, etc. The contact network can also represent spatial or geographical constraints. Network-based models relate to ODE models in the sense that the ODE model represents the mean propagation of an epidemic on an infinite complete graph (all nodes are directly connected), assuming that all nodes are attributed with exponentially distributed jump times. Conceptually, the completeness “removes” the heterogeneity from the interaction structure and the infinite size prevents artifacts from the stochasticity. ### COVID-19 Effects of different contact networks were studied in [25, 67–69]. Contact networks are being used to build realistic simulations of a society, for instance by creating household-structures with various types of inter-household connections [70–73]. The flexibility to control networks modeling NPIs easy [71, 72, 74, 75]. Moreover, [76–78] use a network-based approach for spatial properties (e.g., flow between geographical regions). Although the importance of hubs was recognized very early [79], the concrete relation to overdispersion as it is studied in branching processes remains under-explored. Networks, where the contact structure changes over time, are particularly well-suited to study quarantine measure and social distancing [80–82]. ## Method In this section, we show how to translate a ODE model to a network-based model in order to impose variation in connectivity and infectiousness while keeping the population averages of clinical and transmission parameters fixed. We use a COVID-19 ODE model that is heavily inspired by the SIR-extension of [71]. A summary of the model is depicted in Fig. 2 and Table 1. We do note upfront that we are only interested in qualitative results and do not rely on exact parameter values. View this table: [Table 1.](http://medrxiv.org/content/early/2021/03/26/2021.03.25.21254292/T1) Table 1. Model Parameters ![Fig 2.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2021/03/26/2021.03.25.21254292/F2.medium.gif) [Fig 2.](http://medrxiv.org/content/early/2021/03/26/2021.03.25.21254292/F2) Fig 2. COVID-19 model. **(a)** Transitioning system of the network model with subject-level infectiousness (*λ**i* for subject *i*). The transition rates refer to exponentially distributed residence times. The expected residence time in each disease sage is the inverse of the sum of the outgoing transitions (e.g. for I1 it is 1*/*(*β*1 + *µ*2) = 6 (days)). Likewise, the probability to go to I2 is 0.2.). **(b)** Corresponding ODE model with infection rate *γ*, where *γ* encodes connectivity and infectiousness. ### ODE model Our model contains six disease stages or compartments (cf. Fig. 2): *susceptible* (S), *exposed* (E) (infected but not yet infectious), *removed* (R) (immune or dead), as well as *mild, severe*, and *critical* infection stages (I1, I2, I3). In contrast to [71], we merge dead and recovered stages to a single *removed* stage, as both do not influence the infection dynamics further (we assume immunity after recovery). The fraction of individuals in each compartment evolves according to a system of ordinary differential equations (ODEs) given in Fig. 2b. Unlike network-based models, ODE models admit a semantics that is invariant to the population size. Thus, we assume that the population is normalized. A further difference to [71] is that we only have a single infection parameter *γ*. All other parameters have a meaningful clinical interpretation and can be specified accordingly (cf. Table 1). The set of transition parameters *γ, µ**j*, *β**j* gives raise to a specific *R*. Thus, we can fix *R* and thereby control *γ* [71]. We use *R* = 2.5 which leads to *γ ≈* 0.394. We refer to [71] for clinical justification of *µ**j*, *β**j*. ### Network-based dynamics We consider a static, undirected, unweighted, strongly connected graph. At each point in time, each node (individual) is annotated with a compartment. The dynamics is specified as a continuous-time Markov chain (CTMC) [26] where the labeling changes randomly over time. We use the compartments described in Fig. 2. Nodes change their compartment following exponentially distributed residence times corresponding to specific instantaneous rates. For the transition from *susceptible* top *exposed*, the rate depends on the neighborhood of the node (cf. Fig. 2a). We consider two cases: (i) all nodes have the same infection rate *λ* and (ii): each node *i* has an individual infection rate *λ**i*, sampled from a probability distribution with density *ν*. We start with the former case. #### Case (i): Homogeneous infectiousness Each S *−* I1 can transmit an infection with rate *λ*. If the infected node is in compartment I2 or I3 the infectiousness decreases (e.g., because people stay home) and is given by *λ/z*. Note that we use exponentially distributed residence times which are potentially less realistic than, for instance, beta-distributions [71], but these relate directly to ODE models. Hence, observed differences in the dynamics can be attributed to the connectivity/stochasticity not the shape of the residence time. *R* is defined as the expected number of neighbors that a randomly chosen patient zero infects in a susceptible population, thus *R* cannot be larger than the mean degree (number of neighbors). In the case of a fixed infection rate *λ*, fixing *k*mean also determines *R*. We can approximate *R* as shown in Fig. 3. We use that each infection happens independently and approximate *R* *≈ p*I*k*mean where *p*I denotes the probability that patient zero infects a random neighbor (while potentially transitioning to I2, I3). The approximation comes from the fact that an already infected neighbor can infect another neighbor of patient zero violating the independence assumption, rendering this an over-approximation. Note that *p*I is the conceptually similar to the *secondary attack rate* in a completely susceptible population. We construct the networks such that *k*mean = 8 (except for the complete graph where *k*mean is the number of nodes minus one). Like in ODE-approach, we fix *R* = 2.5 and determine *λ* = 0.0706 (cf. Fig. 3). ![Fig 3.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2021/03/26/2021.03.25.21254292/F3.medium.gif) [Fig 3.](http://medrxiv.org/content/early/2021/03/26/2021.03.25.21254292/F3) Fig 3. Computation of *R* for fixed *λ*. **Right:** The probability that an I1 *−* S edge transmits the infection, *p*I, is the sum of ![Graphic][1] : probably that the infection is transmitted while the infected node is in ![Graphic][2] : probability that I1 transitions to I2 (before transmitting the infection) and transmits while in I2; and ![Graphic][3] : probability that the infection happens in I3 (and not earlier). For individually varying *λ**i*, *R* *≈ k*mean*E*[*p*I] is based on an integral over *ν*. **Left:** Representation of *p*I as a reachability probability (from *Start* to *Goal*) in a CTMC. #### Case (ii): Individual differences in infectiousness In the case of individually varying infectiousness, we associate each node *i* with infection rate *λ**i* that is drawn from a distribution with density *ν*. Again, our goal is to introduce variation while keeping the population mean. Hence, we construct *ν* such that λ = *E*[λi] = 0.0706. We define ![Graphic][4] as the basic reproduction number when the infection starts in node *i* and find that ![Graphic][5] Interestingly, different *ν* (with the same mean) can lead to different *R*. Theoretically, this follows from the computation of *p*I which is now based on an integral over *ν*. In the next section, we set *ν* to be an exponential distribution and study the resulting changes in the dynamics. A key takeaway of our study is that increasing the variance in the degree distribution does not change *R*, increasing the variance in the individual infectiousness does so (in fact, it decreases *R*). For the evaluation, we use an exponentially distributed *λ**i* with mean 0.0706. ### Human-to-human contact networks We test different types of contact networks that highlight different characteristics of real-world human-to-human connectivity. To this end, we describe the contact networks using random graph models. In each simulation, we create a specific realization (variate) of such a random graph model. A schematic visualization of example networks is provided in Fig. 4. We use a **complete graph** (each possible pair of nodes is connected) as a baseline to study the evolution of the epidemic when no contact structure is present. Thereby, we can mimic the effects of stochasticity and variation in infectiousness while keeping the simulation as close as possible to the assumptions underlying the ODE. We also compute results for **Watts–Strogatz** (WS) random networks. They are based on a ring topology with random re-wiring. Each node has exactly *k*mean neighbors. We use a small re-wiring probability of 5% to highlight the locality of real-world epidemics. We use **Power-law Configuration Model** networks to study the effects of hubs (potential super-spreaders). These networks are—except from being constrained on having power-law degree distribution—completely random. The power-law degree distribution is omnipresent in real-world networks and entails a small number of nodes with a very high degree. We fix the minimal degree to be two and choose the power-law parameter numerically such that the network admits the desired mean degree. We also test a synthetically generated **Household** network that was loosely inspired by [83]. Each household is a clique, the edges between households represent connections stemming from work, education, shopping, leisure, etc. We use a geometric network to generate the global inter-household structure. The household size is 4. In the case of *k*mean = 8, each node has 3 edges within its household and (on average) 5 outgoing edges. ![Fig 4.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2021/03/26/2021.03.25.21254292/F4.medium.gif) [Fig 4.](http://medrxiv.org/content/early/2021/03/26/2021.03.25.21254292/F4) Fig 4. Schematic visualizations of random graph models with 80 nodes and *k*mean = 8. ### Dispersion in networks Given a set of independent simulation runs, we measure dispersion by analyzing the empirical offspring distribution at day *t* (averaged over all nodes). Specifically, we consider the offspring distributions of the nodes that were exposed within day *t* (the actual secondary infections may happen later). We also perform a discretization of time over intervals of one day. We quantify dispersion in three ways: * **CoV**: Together with the mean of the offspring distribution *R**t*, we report the *coefficient of variation* (CoV), that is the ratio of the standard deviation to mean. The CoV is a widely-used measure of dispersion of a probability distribution. * **Top-k**: We explicitly report how many new infections within day *t* are caused by which fraction of infected nodes (e.g., 80% of the new infections are caused by 20% of the nodes). We report which fraction of new infections can be traced back to (the most harmful) 10%, 20%, and 30% of infected nodes. * **Offspring**: We report the fraction of nodes (that were infected within day *t*) that lead to 0, 1, 2, … children. ### Experiments We compare the evolution and dispersion of the four network models. We have two main experiments. In the first experiment (overview in Fig. 7), we study a fixed infection rate (mimicking the case that there is only variation in the connectivity). In the second experiment (Fig. 8), we additionally impose individual variation in the infectiousness *λ**i*. Recall that the networks (aside from the complete graph) have approximately the same density (number of edges) and that nodes approximately admit the same mean infectiousness. Thereby, ensure that the resulting differences are solely a consequence of the corresponding variation. Fig. 5 and Fig. 6 summarize some of our findings. Fig. 5 visualizes the effects of adding stochasticity and individual variation to a population. Fig. 6 highlights the different dynamics emerging on different contact networks. ![Fig 5.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2021/03/26/2021.03.25.21254292/F5.medium.gif) [Fig 5.](http://medrxiv.org/content/early/2021/03/26/2021.03.25.21254292/F5) Fig 5. Overview of how population heterogeneity shapes an epidemic. **f.l.t.r**.: ODE model, a complete graph, a power-law network, and a power-law network with exponentially distributed infectiousness. The mean fraction of the population in each compartment at each point in time is shown. Shaded areas indicate standard deviations, not confidence intervals. ![Fig 6.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2021/03/26/2021.03.25.21254292/F6.medium.gif) [Fig 6.](http://medrxiv.org/content/early/2021/03/26/2021.03.25.21254292/F6) Fig 6. Fraction of nodes in I1 (*y*-axis) over time **Left:** Fixed infection rate *λ*. **Right:** Node-based infection rate *λ**i* drawn from an exponential distribution. Note the large difference between the two evolutions on the Watts–Strogatz (WS) networks. Python code is available at [www.github.com/gerritgr/Covid19Dispersion](http://www.github.com/gerritgr/Covid19Dispersion). ### Setup For each network, we perform 1000 simulation runs on a network with 1000 nodes. Networks are generated such that the mean degree is approximately eight. For network models where we cannot directly control *k*mean, we start by generating sparse networks and increase the density until *k*mean has the desired value. In each simulation run, we start with three randomly chosen infected nodes in I1 (to reduce the likelihood of initial instantaneous die-outs). The ODE (cf. Fig. 6) starts with a value of 3*/*1000 in I1. The number of simulation runs is enough to estimate the mean fractions (and the standard deviations) corresponding to each compartment with high accuracy. ### Quantities of interest We characterize epidemics in terms of the evolution of population fractions, that is, mean fraction of nodes in compartment S, I1, R for each time point *t* (the remaining compartments evolve approximately proportional to I1, thus, we leave them out for clarity). This evolution informs about the time point and the height of the infection peak and the final epidemic size (or HIT) that is equivalent to the (mean) fraction of recovered nodes when the epidemic is over (which is mostly the case at 200 time units). Note that the final death toll is proportional to the final epidemic size. Moreover, we study the effective reproduction number *R**t* (2nd row in Fig. 7 and Fig. 8). We define *R**t* to be the average number of secondary infections for a node that got exposed at day *t ∈* ℕ≥0 (we discretize time for this purpose). Thereby, we also report an empirical *R* based on the three initially infected nodes that diverges slightly from the theoretical *R* in Table 1. Dispersion is quantified using the three techniques explained in Section (2nd to 4th row in Fig. 7 and Fig. 8). ![Fig 7.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2021/03/26/2021.03.25.21254292/F7.medium.gif) [Fig 7.](http://medrxiv.org/content/early/2021/03/26/2021.03.25.21254292/F7) Fig 7. **Experiment 1**: Epidemic dynamics of different network types. **Row 1**: Evolution in terms of mean fractions (and standard deviation) in each compartment over time. **Row 2**: Effective reproduction number *R**t* (the empirical *R* is shown as a black triangle) and coefficient of variation of the offspring distribution (with 95% CI, note a significant amount of noise in the power-law case). **Row 3**: Top-*k* plots: The fraction of new infections that can be attributed to a particular fraction of infected nodes. **Row 4**: Characterization of the offspring distribution in terms of the fraction of nodes that cause a specific number of secondary infections. ![Fig 8.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2021/03/26/2021.03.25.21254292/F8.medium.gif) [Fig 8.](http://medrxiv.org/content/early/2021/03/26/2021.03.25.21254292/F8) Fig 8. **Experiment 2**: Epidemic dynamics with individual infectiousness *λ**i* **Row 1**: Evolution in terms of mean fractions in each compartment over time **Row 2**: Effective reproduction number *R**t* and coefficient of variance of the offspring distribution. **Row 3**: Top-*k* plots: what fraction of new infection can be attributed to which fraction of infected nodes. **Row 4**: Characterization of the offspring distribution in terms of what fraction of nodes have how many offspring (infect how many neighbors). ## Experiment 1: Network-based connectivity heterogeneity Results for a fixed *λ* on different network types are shown in Fig. 7. In most simulation runs, the power-law dynamics admits a very early peak and the epidemic dies out early with a comparably small final epidemic size. This effect can directly be attributed to the hubs that get infected very early (because of their high centrality) and jump-start the epidemic. In contrast, in household networks—and even more so in WS networks—the infection peak is lower and happens at a later time point. This is no surprise as the connectivity in both networks imposes a level of locality that slows down the propagation. For better visibility, the differences in the infection curve (based on I1) are summarized in Fig. 6. We also see that the complete graph behaves very similarly to the ODE model. The effective reproduction *R**t* starts from around 2.5 (the theoretical overapproximation) and decreases in most cases monotonically. The exception is again the power-law network where hubs cause a huge jump of *R**t* in the first day from 2.5 to around 12. This jump is also reflected in the dispersion measure, most noticeable in the offspring plot (4th row). The power-law topology generally admits a higher dispersion than the other networks. For instance, the fraction of nodes with zero offspring is much higher. Moreover, on most days, the top 20% of the infected nodes account for more than 80% of the new infections which would roughly fit the estimations for COVID-19 in a typical population. In the other network types, there is less temporal variation of the dispersion. The dispersion is the lowest in the WS networks which is unsurprising as all nodes have degree 8 which provides an upper bound to the offspring number. Generally speaking, we see that dispersion can be measured robustly using the empirical offspring distribution. ## Experiment 2: Individual differences in infectiousness In this experiment, we draw in each simulation run for each node *i* a random *λ**i* that is distributed according to *ν*. Here we use an exponential distribution. The effects on the evolution and dispersion are reported in Fig. 8. In all networks, the epidemic becomes “weaker” in terms of final epidemic size and infection peak height (see also Fig. 6). This effect is strongest in the WS network (where the epidemic dies out almost immediately) and weakest in the complete graph. This is also mirrored in the difference of *R* compared to Experiment 1 (as explained in Fig.-3, the relationship between *λ* and *R* is now non-linear). The complete graph leaves *R* almost unchanged (i.e., around 2.5) while it goes down to around 2.0 in the WS network. Effects on the household and power-law network are less drastic but still evident. Regarding the dispersion, the differences to Experiment 1 are expectable. The variance in the empirical offspring distribution generally increases. Interestingly, this happens in all networks by roughly the same amount regardless of whether the dispersion was high or low in the first case. We can also consistently see the change in dispersion in all three dispersion measures, but it is especially evident in the top-*k* plots (3rd row). It is also interesting to see that all networks admit a characteristic signature in the histogram of the offspring distribution (4th row). The infection rate variation shifts these plots (in particular, because the number of nodes without offspring increases) but they still entail a clear distinction between networks. We also tested uniform and gamma distributions for *ν* (results not shown), and found that the epidemic generally becomes weaker with higher variance. We expect that this is due to an increased likelihood of local and global die-outs. ## Discussion The two experiments show that heterogeneous interaction structures and variations in infectiousness strongly influence key quantities of an epidemic. However, there are important differences between the sources of variations: * The existence of hubs in the network can cause *R**t* to increase, variations in *λ* generally do not cause this behavior. * Different networks with the same *k*mean and a fixed *λ* will (approximately) admit the same *R*. However, choosing densities *ν* of different form (while keeping the mean of the distribution fixed) changes *R*. * Varying infectiousness generally weakens the epidemic’s impact. Varying the connectivity can make some aspects of the epidemic worse (e.g., height of the infection peak in power-law networks). * *λ* has the weakest influence when the interaction structure is homogeneous (i.e., on a complete graph) and the strongest when the interaction structure is based on locality (the average distances in the graph increase) as in the Watts–Strogatz network. * Varying *λ* increases the stochasticity of the epidemic. * The interaction structure has a large influence on the dispersion. Individual infectiousness variations induces a smaller but consistent increase of dispersion. * Hubs influence how the dispersion changes over time. Infectiousness variations increase the dispersion consistently for all time points. Our results underline that networks are a feasible tool to encode a wide variety of different features of a population’s interaction structure. Generally speaking, it is not surprising that some networks support the formation of epidemics better than others. To some extent, this has been studied in terms of the epidemic threshold of graphs [84]. However, the variety of the influence of the networks and the interplay between heterogeneity in the degree of infectiousness and dispersion is remarkable and, to our knowledge, underexplored in literature. There are even further possibilities to adjust population heterogeneity, e.g., by adding non-Markovian residence times in the compartments, by varying the remaining transition rates, or by imposing more temporal variability in infectiousness. Our results already show that models, based on point estimators of population averages (i.e., most mean-field ODE models), are not adequate for analyzing or predicting the dynamics of an epidemic. Regarding the dispersion, we see that no network structure by itself leads to a dispersion where 80% of the infections are caused by only 15% of the infected nodes [19] (at least initially). However, the differences between networks are remarkable. From branching process theory, it is known that a higher dispersion increases the die-out probability [12]. Generally, this effect also holds for networks. For a fixed network, increasing dispersion by using a probabilistic infection rate does, in fact, increase the die-out probability. However, the network topology strongly modulates the strength of this effect. Conclusively, we find that in most cases population diversity makes an epidemic less harmful but increases the dispersion and the variability of the evolution. Hubs in the contact networks are an exception to this rule. These are drivers of the epidemic as they become infected very early and infect many others. This distinguishes them from very infectious people (due to a high viral load) with an average number of contacts who also potentially infect many others. However, a high infectiousness alone does not make them more likely to be infected early enough (i.e., on average earlier than other nodes) to cause an early explosive surge of the epidemic. Hubs also highlight that the effective reproduction number can change significantly while the environmental conditions remain the same simply because the prevalence shifts towards highly connected individuals in the beginning. Considering that an exponentially distributed *λ**i* can be considered a fairly strong assumption about individual differences, our work can—with necessary caution—be seen as further evidence that the network structure plays a more important role for the dispersion than individual viral load variability. Transferring these characteristics to NPIs, our work indicates that reducing long-range connections (e.g., by corresponding mobility restrictions) and keeping degree-variability small (to avoid hubs) are particularly effective control strategies. Reducing mobility seems to be especially effective for overdispersed epidemics. Note that the differences between the WS networks (that admit a high level of locality) and the other networks become even more evident when we vary infectiousness. This can be explained by the observation that in overdispersed epidemics the virus has to be introduced to a susceptible population multiple times before an outbreak becomes likely. ## Conclusions We tested the influence of heterogeneity in the population’s interaction structure and degree of individual infectiousness on the dynamical evolution of an epidemic. We find that the dynamics depends strongly on these properties and that there is an intriguing interplay between these two sources of variation. Our work also highlights the role of small-worldness, local die-outs, and super-spreaders for an epidemic. Discussing epidemics in terms of population averages does not adequately reflect the complexity of the emerging dynamics. Specifically, the widely-used class of ODE models cannot accurately capture population heterogeneity. Naturally, mathematical modeling is based on assumptions and abstractions. However, heterogeneity seems to be particularly vital and excluding it should only be done with great caution. On a high-level, this work highlights limitations of certain model classes and shows that subtle differences in assumptions can make important differences. For future work, it would be interesting to study the effects of heterogeneity and their implications for NPIs empirically. Moreover, we plan to test implications of further sources of heterogeneity, for instance regarding compliance with NPIs, susceptibility to infections, or whether people tend to meet indoors or outdoors. In a broader spectrum, population heterogeneity is only one aspect that may cause models to perform much worse in the real-world than one might expect. This simulation study is a reminder that models are prone to hidden assumptions, and that we should be cautious with their interpretation. ## Data Availability This is a simulation study. Code is available online. [https://github.com/gerritgr/Covid19Dispersion](https://github.com/gerritgr/Covid19Dispersion) ## Acknowledgments This work was partially supported by the DFG project MULTIMODE. * Received March 25, 2021. * Revision received March 25, 2021. * Accepted March 26, 2021. * © 2021, Posted by Cold Spring Harbor Laboratory The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission. ## References 1. 1.Brauner JM, Mindermann S, Sharma M, Johnston D, Salvatier J, Gavenčiak T, et al. Inferring the effectiveness of government interventions against COVID-19. Science. 2020;doi:10.1126/science.abd9338. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Mzoic2NpIjtzOjU6InJlc2lkIjtzOjE3OiIzNzEvNjUzMS9lYWJkOTMzOCI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIxLzAzLzI2LzIwMjEuMDMuMjUuMjEyNTQyOTIuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 2. 2.Adam D. Special report: The simulations driving the world’s response to COVID-19. Nature. 2020;580(7803):316. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/d41586-020-01003-6&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=32242115&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F26%2F2021.03.25.21254292.atom) 3. 3.Bui Q, Katz J, Parlapiano A, Sanger-Katz M. What 5 coronavirus models say the next month will look like. New York Times. 2020;. 4. 4.Kuhl E. Data-driven modeling of COVID-19—Lessons learned. Extreme Mechanics Letters. 2020; p. 100921. 5. 5.Holmdahl I, Buckee C. Wrong but useful—what covid-19 epidemiologic models can and cannot tell us. New England Journal of Medicine. 2020;. 6. 6.Althouse BM, Wenger EA, Miller JC, Scarpino SV, Allard A, Hébert-Dufresne L, et al. Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control. PLoS biology. 2020;18(11):e3000897. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1371/journal.pbio.3000897&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=33180773&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F26%2F2021.03.25.21254292.atom) 7. 7.Shen C, Taleb NN, Bar-Yam Y. Review of Ferguson et al “Impact of nonpharmaceutical interventions..”. New England Complex Systems Institute. 2020;. 8. 8.Cave E. COVID-19 super-spreaders: Definitional quandaries and implications. Asian Bioethics Review. 2020; p. 1. 9. 9.Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Eurosurveillance. 2020;25(4). 10. 10.Adam D, Wu P, Wong J, Lau E, Tsang T, Cauchemez S, et al. Clustering and superspreading potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in Hong Kong. PREPRINT (Version 1) available at Research Square. 2020;. 11. 11.Hasan A, Susanto H, Kasim M, Nuraini N, Triany D, Lestari B. Superspreading in Early Transmissions of COVID-19 in Indonesia. medRxiv. 2020;. 12. 12.Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005;438(7066):355–359. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/nature04153&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=16292310&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F26%2F2021.03.25.21254292.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000233300200048&link_type=ISI) 13. 13.Lloyd-Smith JO. Maximum likelihood estimation of the negative binomial dispersion parameter for highly overdispersed data, with applications to infectious diseases. PloS one. 2007;2(2):e180. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1371/journal.pone.0000180&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17299582&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F26%2F2021.03.25.21254292.atom) 14. 14.Müller J, Hösel V. Contact Tracing & Super-Spreaders in the Branching-Process Model. arXiv preprint arxiv:201004942. 2020;. 15. 15.Cevik M, Marcus J, Buckee C, Smith T. SARS-CoV-2 transmission dynamics should inform policy. Available at SSRN 3692807. 2020;. 16. 16.Endo A, Abbott S, Kucharski AJ, Funk S, et al. Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China. Wellcome Open Research. 2020;5(67):67. 17. 17.Tariq A, Lee Y, Roosa K, Blumberg S, Yan P, Ma S, et al. Real-time monitoring the transmission potential of COVID-19 in Singapore, March 2020. BMC Medicine. 2020;18:1–14. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s12916-020-01597-8&link_type=DOI) 18. 18.Hébert-Dufresne L, Althouse BM, Scarpino SV, Allard A. Beyond R0: Heterogeneity in secondary infections and probabilistic epidemic forecasting. medRxiv. 2020;. 19. 19.Sun K, Wang W, Gao L, Wang Y, Luo K, Ren L, et al. Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2. Science. 2020;doi:10.1126/science.abe2424. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Mzoic2NpIjtzOjU6InJlc2lkIjtzOjE3OiIzNzEvNjUyNi9lYWJlMjQyNCI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIxLzAzLzI2LzIwMjEuMDMuMjUuMjEyNTQyOTIuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 20. 20.Jones TC, Mühlemann B, Veith T, Biele G, Zuchowski M, Hoffmann J, et al. An analysis of SARS-CoV-2 viral load by patient age. medRxiv. 2020;. 21. 21.Walker AS, Pritchard E, House T, Robotham JV, Birrell PJ, Bell I, et al. Viral load in community SARS-CoV-2 cases varies widely and temporally. medRxiv. 2020;. 22. 22.Goyal A, Reeves DB, Cardozo-Ojeda EF, Schiffer JT, Mayer BT. Wrong person, place and time: viral load and contact network structure predict SARS-CoV-2 transmission and super-spreading events. Medrxiv. 2020;. 23. 23.Walsh KA, Jordan K, Clyne B, Rohde D, Drummond L, Byrne P, et al. SARS-CoV-2 detection, viral load and infectivity over the course of an infection: SARS-CoV-2 detection, viral load and infectivity. Journal of Infection. 2020;. 24. 24.Chand M, et al. Investigation of novel SARS-COV-2 variant: Variant of Concern 202012/01 (PDF). Public Health England PHE. 2020;. 25. 25.Großmann G, Backenköhler M, Wolf V. Importance of Interaction Structure and Stochasticity for Epidemic Spreading: A COVID-19 Case Study. ResearchGate (published at 17th International Conference on Quantitative Evaluation of SysTems (QEST 2020), preprint at medRxiv or ResearchGate). 2020;. 26. 26.Kiss IZ, Miller JC, Simon PL, et al. Mathematics of epidemics on networks. Cham: Springer. 2017;598. 27. 27.Ioannidis JP. Coronavirus disease 2019: the harms of exaggerated information and non-evidence-based measures. European journal of clinical investigation. 2020;. 28. 28.Sanguinetti G. Systematic errors in estimates of *R_t* from symptomatic cases in the presence of observation bias. arXiv preprint arxiv:201202105. 2020;. 29. 29.Adiga A, Dubhashi D, Lewis B, Marathe M, Venkatramanan S, Vullikanti A. Mathematical models for covid-19 pandemic: a comparative analysis. Journal of the Indian Institute of Science. 2020; p. 1–15. 30. 30.Anderson RM, Anderson B, May RM. Infectious diseases of humans: dynamics and control. Oxford university press; 1992. 31. 31.Watts DJ, Muhamad R, Medina DC, Dodds PS. Multiscale, resurgent epidemics in a hierarchical metapopulation model. Proceedings of the National Academy of Sciences. 2005;102(32):11157–11162. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMjoiMTAyLzMyLzExMTU3IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjEvMDMvMjYvMjAyMS4wMy4yNS4yMTI1NDI5Mi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 32. 32.Großmann G, Bortolussi L. Reducing spreading processes on networks to Markov population models. In: International Conference on Quantitative Evaluation of Systems. Springer; 2019. p. 292–309. 33. 33.Tang L, Zhou Y, Wang L, Purkayastha S, Zhang L, He J, et al. A Review of Multi-Compartment Infectious Disease Models. International Statistical Review. 2020;88(2):462–513. 34. 34.Dehning J, Zierenberg J, Spitzner FP, Wibral M, Neto JP, Wilczek M, et al. Inferring COVID-19 spreading rates and potential change points for case number forecasts. arXiv preprint arxiv:200401105. 2020;. 35. 35.Louren·o J, Paton R, Ghafari M, Kraemer M, Thompson C, Simmonds P, et al. Fundamental principles of epidemic spread highlight the immediate need for large-scale serological surveys to assess the stage of the SARS-CoV-2 epidemic. medRxiv. 2020;. 36. 36.Khailaie S, Mitra T, Bandyopadhyay A, Schips M, Mascheroni P, Vanella P, et al. Estimate of the development of the epidemic reproduction number Rt from Coronavirus SARS-CoV-2 case data and implications for political measures based on prognostics. medRxiv. 2020;. 37. 37.Stutt RO, Retkute R, Bradley M, Gilligan CA, Colvin J. A modelling framework to assess the likely effectiveness of facemasks in combination with ‘lock-down’in managing the COVID-19 pandemic. Proceedings of the Royal Society A. 2020;476(2238):20200376. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1098/rspa.2020.0376&link_type=DOI) 38. 38.Boudrioua MS, Boudrioua A. Predicting the COVID-19 epidemic in Algeria using the SIR model. medRxiv. 2020;. 39. 39.De Visscher A. The COVID-19 pandemic: model-based evaluation of non-pharmaceutical interventions and prognoses. Nonlinear dynamics. 2020;101(3):1871–1887. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s11071-020-05861-7&link_type=DOI) 40. 40.Barbarossa MV, Fuhrmann J, Meinke JH, Krieg S, Varma HV, Castelletti N, et al. Modeling the spread of COVID-19 in Germany: Early assessment and possible scenarios. Plos one. 2020;15(9):e0238559. 41. 41.Dolbeault J, Turinici G. Heterogeneous social interactions and the COVID-19 lockdown outcome in a multi-group SEIR model. arXiv preprint arxiv:200500049. 2020;. 42. 42.Wilson N, Barnard LT, Kvalsvig A, Baker M. Potential Health Impacts from the COVID-19 Pandemic for New Zealand if Eradication Fails: Report to the NZ Ministry of Health. Government Report. 2020;. 43. 43.Singh R, Adhikari R. Age-structured impact of social distancing on the COVID-19 epidemic in India. arXiv preprint arxiv:200312055. 2020;. 44. 44.Ellison G. Implications of heterogeneous SIR models for analyses of COVID-19. National Bureau of Economic Research; 2020. 45. 45.Prem K, Liu Y, Russell TW, Kucharski AJ, Eggo RM, Davies N, et al. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study. The Lancet Public Health. 2020;. 46. 46.Klepac P, Kucharski AJ, Conlan AJ, Kissler S, Tang M, Fry H, et al. Contacts in context: large-scale setting-specific social mixing matrices from the BBC Pandemic project. medRxiv. 2020;doi:10.1101/2020.02.16.20023754. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMC4wMi4xNi4yMDAyMzc1NHYyIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjEvMDMvMjYvMjAyMS4wMy4yNS4yMTI1NDI5Mi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 47. 47.Afshordi N, Holder B, Bahrami M, Lichtblau D. Diverse local epidemics reveal the distinct effects of population density, demographics, climate, depletion of susceptibles, and intervention in the first wave of COVID-19 in the United States. arXiv preprint arxiv:200700159. 2020;. 48. 48.Humphries R, Spillane M, Mulchrone K, Wieczorek S, O’Riordain M, Hoevel P. A metapopulation network model for the spreading of SARS-CoV-2: Case study for Ireland. medRxiv. 2020;. 49. 49.Cooper I, Mondal A, Antonopoulos CG. A SIR model assumption for the spread of COVID-19 in different communities. Chaos, Solitons & Fractals. 2020;139:110057. [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F26%2F2021.03.25.21254292.atom) 50. 50.Neipel J, Bauermann J, Bo S, Harmon T, Jülicher F. Power-law population heterogeneity governs epidemic waves. PloS one. 2020;15(10):e0239678. 51. 51.Gomes MGM, Aguas R, Corder RM, King JG, Langwig KE, Souto-Maior C, et al. Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold. medRxiv. 2020;. 52. 52.Roda WC, Varughese MB, Han D, Li MY. Why is it difficult to accurately predict the COVID-19 epidemic? Infectious Disease Modelling. 2020;. 53. 53.Comunian A, Gaburro R, Giudici M. Inversion of a SIR-based model: A critical analysis about the application to COVID-19 epidemic. Physica D: Nonlinear Phenomena. 2020;413:132674. 54. 54.Castro M, Ares S, Cuesta JA, Manrubia S. The turning point and end of an expanding epidemic cannot be precisely forecast. Proceedings of the National Academy of Sciences. 2020;117(42):26190–26196. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMjoiMTE3LzQyLzI2MTkwIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjEvMDMvMjYvMjAyMS4wMy4yNS4yMTI1NDI5Mi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 55. 55.Bertozzi AL, Franco E, Mohler G, Short MB, Sledge D. The challenges of modeling and forecasting the spread of COVID-19. arXiv preprint arxiv:200404741. 2020;. 56. 56.Allen LJ. Stochastic population and epidemic models. Mathematical biosciences lecture series, stochastics in biological systems. 2015;. 57. 57.Farrington C, Kanaan M, Gay N. Branching process models for surveillance of infectious diseases controlled by mass vaccination. Biostatistics. 2003;4(2):279–295. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/biostatistics/4.2.279&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=12925522&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F26%2F2021.03.25.21254292.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000182894900009&link_type=ISI) 58. 58.Harris TE, et al. The theory of branching processes. vol. 6. Springer Berlin; 1963. 59. 59.Zhang Y, Li Y, Wang L, Li M, Zhou X. Evaluating transmission heterogeneity and super-spreading event of COVID-19 in a metropolis of China. International Journal of Environmental Research and Public Health. 2020;17(10):3705. 60. 60.Tuite AR, Fisman DN. Reporting, epidemic growth, and reproduction numbers for the 2019 novel coronavirus (2019-nCoV) epidemic. Annals of Internal Medicine. 2020;172(8):567–568. [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F26%2F2021.03.25.21254292.atom) 61. 61.Slavtchova-Bojkova M. Branching processes modelling for coronavirus (COVID’19) pandemic. 13th International Conference on Information Systems and Grid Technologies, ISGT 2020. 2020;2656. 62. 62.Yanev NM, Stoimenova VK, Atanasov DV. Branching stochastic processes as models of Covid-19 epidemic development. arXiv preprint arxiv:200414838. 2020;. 63. 63.Levesque J, Maybury DW, Shaw RD. A model of COVID-19 propagation based on a gamma subordinated negative binomial branching process. Journal of Theoretical Biology. 2020; p. 110536. 64. 64.Pastor-Satorras R, Castellano C, Van Mieghem P, Vespignani A. Epidemic processes in complex networks. Reviews of modern physics. 2015;87(3):925. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1103/RevModPhys.87.925&link_type=DOI) 65. 65.Nowzari C, Preciado VM, Pappas GJ. Analysis and control of epidemics: A survey of spreading processes on complex networks. IEEE Control Systems Magazine. 2016;36(1):26–46. 66. 66.Salehi M, Sharma R, Marzolla M, Magnani M, Siyari P, Montesi D. Spreading processes in multilayer networks. IEEE Transactions on Network Science and Engineering. 2015;2(2):65–83. 67. 67.Wolfram C. An agent-based model of Covid-19. Complex Syst. 2020;29:87–105. 68. 68.Reich O, Shalev G, Kalvari T. Modeling COVID-19 on a network: super-spreaders, testing and containment. medRxiv. 2020;. 69. 69.Liu C, Wu X, Niu R, Wu X, Fan R. A new SAIR model on complex networks for analysing the 2019 novel coronavirus (COVID-19). Nonlinear Dynamics. 2020;101(3):1777–1787. 70. 70.Munday JD, Sherratt K, Meakin S, Endo A, Pearson CA, Hellewell J, et al. Implications of the school-household network structure on SARS-CoV-2 transmission under different school reopening strategies in England. medRxiv. 2020;. 71. 71.Nande A, Adlam B, Sheen J, Levy MZ, Hill AL. Dynamics of COVID-19 under social distancing measures are driven by transmission network structure. PLOS Computational Biology. 2021;17(2):e1008684. 72. 72.Kerr CC, Stuart RM, Mistry D, Abeysuriya RG, Hart G, Rosenfeld K, et al. Covasim: an agent-based model of COVID-19 dynamics and interventions. medRxiv. 2020;. 73. 73.Aleta A, de Arruda GF, Moreno Y. Data-driven contact structures: from homogeneous mixing to multilayer networks. arXiv preprint arxiv:200306946. 2020;. 74. 74.Karaivanov A. A Social Network Model of COVID-19. Available at SSRN 3584895. 2020;. 75. 75.Nielsen BF, Sneppen K. COVID-19 superspreading suggests mitigation by social network modulation. medRxiv. 2020;. 76. 76.Silva CJ, Cantin G, Cruz C, Fonseca-Pinto R, da Fonseca RP, Santos ESd, et al. Complex network model for COVID-19: human behavior, pseudo-periodic solutions and multiple epidemic waves. arXiv preprint arxiv:201002368. 2020;. 77. 77.Biswas K, Khaleque A, Sen P. Covid-19 spread: Reproduction of data and prediction using a SIR model on Euclidean network. arXiv preprint arxiv:200307063. 2020;. 78. 78.Pujari BS, Shekatkar SM. Multi-city modeling of epidemics using spatial networks: Application to 2019-nCov (COVID-19) coronavirus in India. medRxiv. 2020;. 79. 79.Pastor-Satorras R, Vespignani A. Epidemic spreading in scale-free networks. Physical review letters. 2001;86(14):3200. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1103/PhysRevLett.86.3200&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=11290142&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F26%2F2021.03.25.21254292.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000167866300072&link_type=ISI) 80. 80.Mancastroppa M, Burioni R, Colizza V, Vezzani A. Active and inactive quarantine in epidemic spreading on adaptive activity-driven networks. arXiv preprint arxiv:200407902. 2020;. 81. 81.Horstmeyer L, Kuehn C, Thurner S. Balancing quarantine and self-distancing measures in adaptive epidemic networks. arXiv preprint arxiv:201010516. 2020;. 82. 82.Fagiolo G. Assessing the Impact of Social Network Structure on the Diffusion of Coronavirus Disease (COVID-19): A Generalized Spatial SEIRD Model. arXiv preprint arxiv:201011212. 2020;. 83. 83.Ball F, Sirl D, Trapman P. Analysis of a stochastic SIR epidemic on a random network incorporating household structure. Mathematical Biosciences. 2010;224(2):53–73. [PubMed](http://medrxiv.org/lookup/external-ref?access_num=20005881&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F03%2F26%2F2021.03.25.21254292.atom) 84. 84.Prakash BA, Chakrabarti D, Valler NC, Faloutsos M, Faloutsos C. Threshold conditions for arbitrary cascade models on arbitrary networks. Knowledge and information systems. 2012;33(3):549–575. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s10115-012-0520-y&link_type=DOI) [1]: F3/embed/inline-graphic-1.gif [2]: F3/embed/inline-graphic-2.gif [3]: F3/embed/inline-graphic-3.gif [4]: /embed/inline-graphic-4.gif [5]: /embed/inline-graphic-5.gif